| # | % | |||||
|---|---|---|---|---|---|---|
| 351 | ATRICURE INC | 45,625 | 672,000 | 0.01% | ||
| 352 | LOXO ONCOLOGY INC COM | 50,449 | 662,000 | 0.01% | ||
| 353 | AFFIMED N V COM | 100,000 | 630,000 | 0.01% | ||
| 354 | REVANCE THERAPEUTICS INC COM | 32,360 | 626,000 | 0.01% | ||
| 355 | Gevo Inc | 1,567,064 | 537,000 | 0.01% | ||
| 356 | FCB Financial Holdings Inc | 38,216 | 534,000 | 0.01% | ||
| 357 | MANCHESTER UTD PLC NEW ORD CL A | 31,656 | 522,000 | 0.01% | ||
| 358 | AERIE PHARMACEUTICALS INC COM | 24,927 | 516,000 | 0.01% | ||
| 359 | QUINSTREET INC COM USD0.001 | 117,797 | 489,000 | 0.01% | ||
| 360 | Vocera Communications Inc | 59,630 | 481,000 | 0.01% | ||
| 361 | APPLIED GENETIC TECHNOL CORP | 25,827 | 481,000 | 0.01% | ||
| 362 | LINCOLN EDL SVCS CORP | 154,280 | 434,000 | 0.01% | ||
| 363 | ADAMAS PHARMACEUTICALS INC | 21,978 | 409,000 | 0.01% | ||
| 364 | MARRONE BIO INNOVATIONS INC | 125,412 | 334,000 | 0.01% | ||
| 365 | TETRALOGIC PHARMA CO | 79,196 | 329,000 | 0.01% | ||
| 366 | FATE THERAPEUTICS INC | 51,482 | 263,000 | 0.01% | ||
| 367 | CYTOKINETICS INC | 65,789 | 232,000 | 0.00% | Call | |
| 368 | GENOCEA BIOSCIENCES INC | 25,000 | 226,000 | 0.00% | ||
| 369 | XENCOR INC COM | 23,667 | 220,000 | 0.00% | ||
| 370 | MACROGENICS INC | 10,435 | 218,000 | 0.00% | ||
| 371 | GLYCOMIMETICS INC | 30,088 | 209,000 | 0.00% | ||
| 372 | Agile Therapeutics, Inc. | 25,850 | 189,000 | 0.00% | ||
| 373 | CELLADON CORP | 14,300 | 150,000 | 0.00% | ||
| 374 | ACHAOGEN INC COM | 13,414 | 120,000 | 0.00% | ||
| 375 | UNIQURE NV | 12,050 | 111,000 | 0.00% | ||
| 376 | CYTOKINETICS INC | 30,881 | 109,000 | 0.00% | ||
| 377 | AURIS MED HLDG AG | 15,300 | 88,000 | 0.00% | ||
| 378 | HARTFORD FINL SVCS GROUP INC | 900 | 34,000 | 0.00% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001164691-14-000207, filed 2014.11.14), New Holdings filing (0001164691-15-000179, filed 2015.11.19), New Holdings filing (0001164691-15-000140, filed 2015.08.17), New Holdings filing (0001164691-15-000101, filed 2015.05.21). and New Holdings filing (0001164691-15-000056, filed 2015.02.18).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
